TipRanks
Go Ultimate55% OFF

GenSight Biologics SA (0RIM) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0RIM Analyst Ratings

There are no analyst ratings in the last 3 months.

0RIM Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0RIM
Price TargetFollowArticle
Chardan CapitalEUR 0.08hold9.74%UpsideReiterated07/15/26
Kepler Capital EUR 0.40hold448.70%UpsideReiterated04/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GenSight Biologics SA

3 Months
Google Health Care EU
Google Health Care EUTipRanks - Google
Success Rate3/6 ratings generated profit
50%
Average Return
+5.33%

Copying Google Health Care EU's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.33% per trade.

1 Year
Google Health Care EU
Google Health Care EUTipRanks - Google
Success Rate2/6 ratings generated profit
33%
Average Return
-1.12%

Copying Google Health Care EU's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -1.12% per trade.

2 Years
Google Health Care EU
Google Health Care EUTipRanks - Google
Success Rate2/6 ratings generated profit
33%
Average Return
-1.12%

Copying Google Health Care EU's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -1.12% per trade.

0RIM Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0RIM
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy00000
Hold11100
Sell00000
Strong Sell00000
total11100

In the current month, 0RIM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RIM average Analyst price target in the past 3 months is ―.

0RIM Financial Forecast

EUR -2EUR -1.5EUR -1EUR -0.5EUR 0Q2 2025Q2 2026Q4 2026
ConsensusEUR -0.05

0RIM Earnings Forecast

Next quarter’s earnings estimate for 0RIM is -EUR 0.05 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR -1.2MEUR -804,250.5EUR -398,500EUR 7,250.5EUR 413,001Q2 2025Q2 2026Q4 2026
ConsensusEUR -1.21M

0RIM Sales Forecast

Next quarter’s sales forecast for 0RIM is -EUR 1.21M with a range of ― to ―. The previous quarter’s sales results were -EUR 1.21M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0RIM Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about GenSight Biologics SA?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of GenSight Biologics SA?
To buy shares of GB:0RIM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.